Mohamed A. Helal

914 total citations
46 papers, 691 citations indexed

About

Mohamed A. Helal is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Mohamed A. Helal has authored 46 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Organic Chemistry and 8 papers in Computational Theory and Mathematics. Recurrent topics in Mohamed A. Helal's work include Receptor Mechanisms and Signaling (11 papers), Computational Drug Discovery Methods (8 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Mohamed A. Helal is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Computational Drug Discovery Methods (8 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Mohamed A. Helal collaborates with scholars based in Egypt, United States and Saudi Arabia. Mohamed A. Helal's co-authors include Samia M. Mostafa, Alyaa Dawoud, Abdallah S. Abdelsattar, Khaled M. Darwish, Ismail Salama, Mohamed S. Gomaa, Amar G. Chittiboyina, Eman S. Habib, Mohamed Saleh Elgawish and Nagwa El‐Badri and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Mohamed A. Helal

41 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed A. Helal Egypt 17 327 177 81 78 59 46 691
Durgesh Kumar India 21 345 1.1× 201 1.1× 187 2.3× 127 1.6× 50 0.8× 62 1.0k
Yajun Yang China 16 306 0.9× 182 1.0× 41 0.5× 86 1.1× 91 1.5× 44 792
Vivek Chandramohan India 17 243 0.7× 201 1.1× 170 2.1× 52 0.7× 77 1.3× 49 804
Bader Alshehri Saudi Arabia 18 271 0.8× 106 0.6× 149 1.8× 45 0.6× 125 2.1× 43 818
Maha M. Abdel‐Fattah Egypt 19 314 1.0× 271 1.5× 125 1.5× 56 0.7× 106 1.8× 58 902
Ismail Salama Egypt 17 271 0.8× 234 1.3× 84 1.0× 39 0.5× 82 1.4× 42 652
Mamunur Rashid India 17 278 0.9× 122 0.7× 36 0.4× 32 0.4× 76 1.3× 50 740
Karim Mahnam Iran 15 279 0.9× 111 0.6× 93 1.1× 30 0.4× 59 1.0× 61 582
Komal Kalani India 15 283 0.9× 89 0.5× 85 1.0× 44 0.6× 50 0.8× 26 560
Kalicharan Sharma India 16 273 0.8× 221 1.2× 80 1.0× 190 2.4× 52 0.9× 70 822

Countries citing papers authored by Mohamed A. Helal

Since Specialization
Citations

This map shows the geographic impact of Mohamed A. Helal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed A. Helal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed A. Helal more than expected).

Fields of papers citing papers by Mohamed A. Helal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed A. Helal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed A. Helal. The network helps show where Mohamed A. Helal may publish in the future.

Co-authorship network of co-authors of Mohamed A. Helal

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed A. Helal. A scholar is included among the top collaborators of Mohamed A. Helal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed A. Helal. Mohamed A. Helal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Alshaman, Reem, et al.. (2025). Recent Advances in the Development of Pro-PROTAC for Selective Protein Degradation. Pharmaceutics. 17(9). 1160–1160.
5.
Helal, Mohamed A., Amar G. Chittiboyina, & Mitchell A. Avery. (2023). Structure-based design of novel melanin-concentrating hormone receptor-1 ligands based on saturated nitrogen-containing heterocycles. Bioorganic & Medicinal Chemistry Letters. 84. 129194–129194. 1 indexed citations
6.
El‐Sayed, Mohamed H., Mohamed Ahmed Eladl, Noha E. Farag, et al.. (2023). Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-κB pathway: Molecular docking and biological investigations. Biomedicine & Pharmacotherapy. 164. 114917–114917. 20 indexed citations
7.
Fallica, Antonino N., Valeria Pittalà, Maria Modica, et al.. (2021). Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective. Journal of Medicinal Chemistry. 64(12). 7926–7962. 48 indexed citations
8.
Darwish, Khaled M., et al.. (2021). Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study. Journal of Molecular Graphics and Modelling. 106. 107940–107940. 19 indexed citations
9.
El‐Sherbiny, Mohamed, Mohamed A. Helal, Mohamed Ahmed Eladl, et al.. (2021). Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling. Molecules. 26(22). 6858–6858. 16 indexed citations
10.
11.
Intagliata, Sebastiano, Mohamed A. Helal, Valeria Pittalà, et al.. (2020). Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands. Molecules. 25(8). 1851–1851. 2 indexed citations
12.
Helal, Mohamed A., et al.. (2019). Zinc ternary complexes with gabapentin and neurotransmitters: Synthesis, spectral, thermal and molecular docking studies. Journal of Molecular Structure. 1199. 126951–126951. 7 indexed citations
13.
Helal, Mohamed A., et al.. (2019). Development and validation of an HPLC-UV method for simultaneous determination of sildenafil and tramadol in biological fluids: Application to drug-drug interaction study. Journal of Pharmaceutical and Biomedical Analysis. 168. 201–208. 31 indexed citations
14.
McLean, Kirsty J., Mohamed A. Helal, Mohamed S. Gomaa, et al.. (2019). Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1. Bioorganic & Medicinal Chemistry. 27(8). 1546–1561. 17 indexed citations
15.
Darwish, Khaled M., Ismail Salama, Samia M. Mostafa, et al.. (2018). Synthesis, biological evaluation, and molecular docking investigation of benzhydrol- and indole-based dual PPAR-γ/FFAR1 agonists. Bioorganic & Medicinal Chemistry Letters. 28(9). 1595–1602. 25 indexed citations
16.
Salama, Ismail, et al.. (2017). Discovery of tetrahydro-ß-carboline derivatives as a new class of phosphodiesterase 4 inhibitors. Medicinal Chemistry Research. 26(12). 3173–3187. 10 indexed citations
17.
Helal, Mohamed A., Eman S. Habib, & Amar G. Chittiboyina. (2017). Selective kappa opioid antagonists for treatment of addiction, are we there yet?. European Journal of Medicinal Chemistry. 141. 632–647. 30 indexed citations
18.
Abdallah, Amira E. M., et al.. (2015). Heterocyclization, Dyeing Applications and Anticancer Evaluations of Benzimidazole Derivatives: Novel Synthesis of Thiophene, Triazole and Pyrimidine Derivatives. Egyptian Journal of Chemistry. 58(6). 699–719. 8 indexed citations
19.
Darwish, Khaled M., Ismail Salama, Samia M. Mostafa, Mohamed S. Gomaa, & Mohamed A. Helal. (2015). Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists. European Journal of Medicinal Chemistry. 109. 157–172. 56 indexed citations
20.
Helal, Mohamed A., et al.. (2013). Design, synthesis, and enzyme kinetics of novel benzimidazole and quinoxaline derivatives as methionine synthase inhibitors. Bioorganic & Medicinal Chemistry. 22(1). 550–558. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026